Trinity Biotech R&D Spending Growth & History (TRIB)

Trinity Biotech's r&d spending was $3.6M for fiscal 2025.

View full Trinity Biotech company overview

Trinity Biotech annual r&d spending history

Trinity Biotech annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$3.6M−$914,000−20.12%
20242024-12-31$4.5M$164,000+3.75%
20232023-12-31$4.4M$241,000+5.82%
20222022-12-31$4.1M−$359,000−7.98%
20212021-12-31$4.5M−$583,000−11.48%
20202020-12-31$5.1M−$245,000−4.60%
20192019-12-31$5.3M−$44,000−0.82%
20182018-12-31$5.4M−$288,000−5.09%
20172017-12-31$5.7M$617,000+12.24%
20162016-12-31$5.0M−$29,000−0.57%
20152015-12-31$5.1M

Trinity Biotech r&d spending trends

Over the last five fiscal years, Trinity Biotech's r&d spending decreased from $5.1M to $3.6M, a change of −$1.5M. The latest reported quarter, Q4 2024, shows $1.5M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Trinity Biotech source filings ↗

Community posts

It’s quiet here.

No posts about TRIB yet. Start the conversation.

Write the first post